Clinical Trials Outsourcing Market

Table Of Content

1.Executive Summary

1.1. Regional Market Share

1.2.Business Trends

1.3. Clinical Trials Outsourcing Market: COVID-19 Outbreak

1.4. Regional Trends

1.5. Segmentation Snapshot

2. Research Methodology

2.1.Research Objective 

2.2. Research Approach 

2.3. Data Sourcing and Methodology

2.4.Primary Research

2.5.Secondary Research

2.5.1.Paid Sources

2.5.2. Public Sources 

2.6. Market Size Estimation and Data Triangulation 

3. Market Characteristics 

3.1.Market Definition

3.2.Clinical Trials Outsourcing Market: COVID-19 Impact

3.3. Key Segmentations 

3.4.Key Developments

3.5.Allied Industry Data

4.Clinical Trials Outsourcing Market – Industry Insights

4.1. Industry Segmentation

4.2.COVID-19 overview of world economy

4.3.Industry Ecosystem Channel Analysis

4.4.Innovation & Sustainability

5. Macroeconomic Indicators

6. Recent Developments

7. Market Dynamics

7.1.Introduction

7.2. Growth Drivers

7.3. Market Opportunities 

7.4.Market Restraints

7.5. Market Trends

8.Risk Analysis

9. Market Analysis

9.1.Porter's Five Forces

9.2. PEST Analysis

9.2.1.Political

9.2.2. Economic

9.2.3. Social

9.2.4. Technological

10.Clinical Trials Outsourcing Market

10.1.Overview

10.2. Historical Analysis (2019-2022)

10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

11. Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F 

11.1. Overview 

11.2.Key Findings

11.3.Market Segmentation

11.3.1. By Phase

11.3.1.1. Phase I

11.3.1.1.1.By Value (USD Million) 2024-2034F

11.3.1.1.2. Market Share (%) 2024-2034F

11.3.1.1.3. Y-o-Y Growth (%) 2024-2034F

11.3.1.2.Phase II

11.3.1.2.1. By Value (USD Million) 2024-2034F

11.3.1.2.2.Market Share (%) 2024-2034F

11.3.1.2.3.Y-o-Y Growth (%) 2024-2034F

11.3.1.3.Phase III

11.3.1.3.1. By Value (USD Million) 2024-2034F

11.3.1.3.2.Market Share (%) 2024-2034F

11.3.1.3.3.Y-o-Y Growth (%) 2024-2034F

11.3.1.4.Phase IV

11.3.1.4.1. By Value (USD Million) 2024-2034F

11.3.1.4.2.Market Share (%) 2024-2034F

11.3.1.4.3.Y-o-Y Growth (%) 2024-2034F

11.3.2. By Application

11.3.2.1.Cancer

11.3.2.1.1. By Value (USD Million) 2024-2034F

11.3.2.1.2.Market Share (%) 2024-2034F

11.3.2.1.3.Y-o-Y Growth (%) 2024-2034F

11.3.2.2. Cardiovascular Diseases

11.3.2.2.1.By Value (USD Million) 2024-2034F

11.3.2.2.2. Market Share (%) 2024-2034F

11.3.2.2.3. Y-o-Y Growth (%) 2024-2034F

11.3.2.3.Nervous System Diseases

11.3.2.3.1.By Value (USD Million) 2024-2034F

11.3.2.3.2. Market Share (%) 2024-2034F

11.3.2.3.3. Y-o-Y Growth (%) 2024-2034F

11.3.2.4. Infectious Diseases

11.3.2.4.1.By Value (USD Million) 2024-2034F

11.3.2.4.2. Market Share (%) 2024-2034F

11.3.2.4.3. Y-o-Y Growth (%) 2024-2034F

11.3.2.5. Musculoskeletal Disease

11.3.2.5.1.By Value (USD Million) 2024-2034F

11.3.2.5.2. Market Share (%) 2024-2034F

11.3.2.5.3. Y-o-Y Growth (%) 2024-2034F

11.3.2.6. Gastroenterology Diseases

11.3.2.6.1.By Value (USD Million) 2024-2034F

11.3.2.6.2. Market Share (%) 2024-2034F

11.3.2.6.3. Y-o-Y Growth (%) 2024-2034F

11.3.2.7. Others

11.3.2.7.1.By Value (USD Million) 2024-2034F

11.3.2.7.2. Market Share (%) 2024-2034F

11.3.2.7.3. Y-o-Y Growth (%) 2024-2034F

11.3.3.By Services Type

11.3.3.1.Protocol Designing

11.3.3.1.1. By Value (USD Million) 2024-2034F

11.3.3.1.2.Market Share (%) 2024-2034F

11.3.3.1.3.Y-o-Y Growth (%) 2024-2034F

11.3.3.2. Site Identification

11.3.3.2.1.By Value (USD Million) 2024-2034F

11.3.3.2.2. Market Share (%) 2024-2034F

11.3.3.2.3. Y-o-Y Growth (%) 2024-2034F

11.3.3.3. Patient Recruitment

11.3.3.3.1.By Value (USD Million) 2024-2034F

11.3.3.3.2. Market Share (%) 2024-2034F

11.3.3.3.3. Y-o-Y Growth (%) 2024-2034F

11.3.3.4. Laboratory Services

11.3.3.4.1.By Value (USD Million) 2024-2034F

11.3.3.4.2. Market Share (%) 2024-2034F

11.3.3.4.3. Y-o-Y Growth (%) 2024-2034F

11.3.3.5. Bioanalytical Testing Services

11.3.3.5.1.By Value (USD Million) 2024-2034F

11.3.3.5.2. Market Share (%) 2024-2034F

11.3.3.5.3. Y-o-Y Growth (%) 2024-2034F

11.3.3.6. Clinical Trial Data Management Services

11.3.3.6.1.By Value (USD Million) 2024-2034F

11.3.3.6.2. Market Share (%) 2024-2034F

11.3.3.6.3. Y-o-Y Growth (%) 2024-2034F

11.3.3.7. Others

11.3.3.7.1.By Value (USD Million) 2024-2034F

11.3.3.7.2. Market Share (%) 2024-2034F

11.3.3.7.3. Y-o-Y Growth (%) 2024-2034F

11.3.4.By End-User

11.3.4.1.Pharmaceutical & Biopharmaceutical Companies

11.3.4.1.1. By Value (USD Million) 2024-2034F

11.3.4.1.2.Market Share (%) 2024-2034F

11.3.4.1.3.Y-o-Y Growth (%) 2024-2034F

11.3.4.2. Medical Device Companies

11.3.4.2.1.By Value (USD Million) 2024-2034F

11.3.4.2.2. Market Share (%) 2024-2034F

11.3.4.2.3. Y-o-Y Growth (%) 2024-2034F

11.3.4.3. Others

11.3.4.3.1.By Value (USD Million) 2024-2034F

11.3.4.3.2. Market Share (%) 2024-2034F

11.3.4.3.3. Y-o-Y Growth (%) 2024-2034F

12.North America Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F

12.1.Overview 

12.2. Key Findings

12.3. Market Segmentation

12.3.1. By Phase

12.3.2.By Application

12.3.3.By Services Type

12.3.4. By End-User

12.4. Country

12.4.1. United States

12.4.2. Canada

13.Europe Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F

13.1.Overview 

13.2. Key Findings

13.3. Market Segmentation

13.3.1.By Phase

13.3.2.By Application

13.3.3.By Services Type

13.3.4. By End-User

13.4.Country

13.4.1.Germany

13.4.2. United Kingdom

13.4.3. France

13.4.4. Italy

13.4.5. Spain

13.4.6. Russia

13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14.Asia-Pacific Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F

14.1. Overview 

14.2. Key Findings

14.3.Market Segmentation

14.3.1.By Phase

14.3.2. By Application

14.3.3. By Services Type

14.3.4. By End-User

14.4. Country

14.4.1.India

14.4.2. China

14.4.3. South Korea

14.4.4.Japan

14.4.5.Rest of APAC

15.Middle East and Africa Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F

15.1.Overview 

15.2. Key Findings

15.3. Market Segmentation

15.3.1.By Phase

15.3.2.By Application

15.3.3.By Services Type

15.3.4. By End-User

15.4.Country 

15.4.1. Israel 

15.4.2. GCC

15.4.3. North Africa

15.4.4.South Africa

15.4.5. Rest of Middle East and Africa

16. Latin America Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F

16.1.Overview 

16.2. Key Findings

16.3. Market Segmentation

16.3.1. By Phase

16.3.2.By Application

16.3.3.By Services Type

16.3.4. By End-User

16.4.Country

16.4.1. Mexico

16.4.2. Brazil

16.4.3. Rest of Latin America

17. Competitive Landscape

17.1.Company market share, 2023

17.2. Key player overview

17.3. Key stakeholders

18. Company Profiles 

18.1. QuintilesIMS (IQVIA)

18.1.1.Company Overview

18.1.2.Financial Overview

18.1.3.Key Product; Analysis

18.1.4.Company Assessment

18.1.4.1.Product Portfolio

18.1.4.2.Key Clients

18.1.4.3. Market Share 

18.1.4.4. Recent News & Development (Last 3 Yrs.)

18.1.4.5. Executive Team

18.2. Covance (LabCorp)

18.3. Parexel International

18.4. Charles River Laboratories

18.5. Medpace

18.6. ICON plc

18.7. PRA Health Sciences

18.8. Syneos Health

18.9. Wuxi AppTec

18.10. PPD

18.11.Eurofins Scientific

18.12. Clinipace

18.13. KCR

18.14. Worldwide Clinical Trials

18.15. Advanced Clinical

18.16. Other Prominent Players

19. Appendix

20.Consultant Recommendation